# Clinical and Sociodemographic Characterization of Multiple Myeloma Participants With Symptomatic Relapse and/or Refractory Disease in Spain (CharisMMa Study)

> **NCT03188536** · — · COMPLETED · sponsor: **Takeda** · enrollment: 282 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT03188536
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-26
- **Primary completion:** 2018-11-15
- **Final completion:** 2019-01-30
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2020-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03188536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03188536, "Clinical and Sociodemographic Characterization of Multiple Myeloma Participants With Symptomatic Relapse and/or Refractory Disease in Spain (CharisMMa Study)". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03188536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*